Skip to content
POM-V Prescription Required Companion Animal

Bravecto 1 400 mg Spot-on Solution for Very Large Dogs (>40 – 56 kg)

Active ingredient: Fluralaner

Form

Spot-on

Species

Dogs

Manufacturer

MSD Animal Health UK Limited

VMD MA No.

01708/5020

What it's used for

For the treatment of tick and flea infestations in dogs. This veterinary medicinal product is a systemic insecticide and acaricide that provides: -Ctenocep...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Fluralaner

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Bravecto 1 400 mg Spot-on Solution for Very Large Dogs (>40 – 56 kg) — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 18 Mar 2026.

For the treatment of tick and flea infestations in dogs.
This veterinary medicinal product is a systemic insecticide and acaricide that
provides:
-Ctenocephalides felis Ctenocephalides canis)
killing activity for 12 weeks, and
-Ixodes ricinus, Rhipicephalus sanguineus
Dermacentor reticulatus) killing activity for 12 weeks.
Fleas and ticks must attach to the host and commence feeding in order to be
exposed to the active substance.
The veterinary medicinal product can be used as part of a treatment strategy for the
control of flea allergy dermatitis (FAD).

Amended Pages: September 2025
AN: 00732/2025
For the treatment of demodicosis caused by Demodex canis.
For the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Dogs:
Common
(1 to 10 animals / 100 animals
treated):
Skin reactions at the application site (such as
Erythema, Alopecia)
#
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Lethargy, Anorexia;
Emesis, Diarrhoea;
Pruritus;
Muscle tremor, Ataxia, Convulsion.
#
mild and transient
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national

Amended Pages: September 2025
AN: 00732/2025
competent authority via the national reporting system. See also the last section of the
package leaflet for respective contact details.
Parasites need to start feeding on the host to become exposed to fluralaner;
therefore the risk of the transmission of parasite borne diseases cannot be excluded.
Unnecessary use of antiparasitics or use deviating from the instructions given in the
SPC may increase the resistance selection pressure and lead to reduced efficacy.
The decision to use the veterinary medicinal product should be based on
confirmation of the parasitic species and burden, or of the risk of infestation based on
its epidemiological features, for each individual animal.
The possibility that other animals in the same household can be a source of re-
infection with parasites should be considered, and these should be treated as
necessary with an appropriate veterinary medicinal product.

Special precautions for use in animals:
Care should be taken to avoid contact with the eyes of the animal.
Do not use directly on skin lesions.
Do not wash or allow the dog to become immersed in water or swim in water courses
within 3 days after treatment.
In the absence of available data, this veterinary medicinal product should not be used
on puppies less than 8 weeks old and /or dogs weighing less than 2 kg.
The veterinary medicinal product should not be administered at intervals shorter than
8 weeks as the safety at shorter intervals has not been tested.
This veterinary medicinal product is for topical use and should not be administered
orally.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Contact with the veterinary medicinal product should be avoided and disposable
protective gloves obtained with this veterinary medicinal product at the point of sale
must be worn when handling the veterinary medicinal product for the following
reasons:
Hypersensitivity reactions have been reported in a small number of people, which
can potentially be serious.
Persons with a hypersensitivity to fluralaner or to any of the excipients should avoid
any exposure to the veterinary medicinal product.
The veterinary medicinal product binds to skin and may also bind to surfaces after
spillage of the veterinary medicinal product. Skin rashes, tingling or numbness have
been reported in a small number of individuals after skin contact.

Amended Pages: September 2025
AN: 00732/2025
If skin contact does occur, wash the affected area immediately with soap and water.
In some cases, soap and water are not sufficient to remove the veterinary medicinal
product spilled on the fingers.
Contact with the veterinary medicinal product may also occur when handling the
treated animal.
Make sure that your animal’s application site is no longer noticeable before resuming
contact with the site of application. This includes cuddling the animal and sharing a
bed with the animal. It takes up to 48 hours for the application site to become dry but
it will be noticeable for longer.
If skin reactions occur, consult a physician and show them the veterinary medicinal
product packaging.
People with a sensitive skin or known allergy in general e.g. to other veterinary
medicinal products of this type should handle the veterinary medicinal product as well
as treated animals with caution.
This veterinary medicinal product can cause eye irritation. In case of contact with the
eyes, immediately rinse thoroughly with water.
This veterinary medicinal product is harmful after ingestion. Keep the veterinary
medicinal product in the original packaging until use, in order to prevent children from
getting direct access to the veterinary medicinal product. A used pipette should
immediately be disposed of. In case of accidental ingestion, seek medical advice and
show the package leaflet or the label to the physician.
The veterinary medicinal product is highly flammable. Keep away from heat, sparks,
open flame or other sources of ignition.In case of spillage onto, for example table or
floor surfaces, remove excess veterinary medicinal product using paper tissue and
clean the area with detergent.
Special precautions for the protection of the environment:
Treated dogs should not be allowed to enter surface water for 48 hours after
treatment to avoid adverse effects on aquatic organisms.
Other precautions:
Not applicable.
None known.
Fluralaner is highly bound to plasma proteins and might compete with other highly
bound active substances such as non-steroidal anti-inflammatory drugs (NSAIDs)
and the coumarin derivative warfarin. Incubation of fluralaner in the presence of
carprofen or warfarin in dog plasma at maximum expected plasma concentrations did
not reduce the protein binding of fluralaner, carprofen or warfarin.
During laboratory and clinical field testing, no interactions between the veterinary
medicinal product and routinely used veterinary medicinal products were observed.
This veterinary medicinal product does not require any special temperature storage
conditions. The pipettes should be kept in the outer packaging to prevent solvent loss
or moisture uptake. The sachets should only be opened immediately prior to use.
1 400
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.